Page last updated: 2024-10-31

nalidixic acid and Hypoglycemia

nalidixic acid has been researched along with Hypoglycemia in 1 studies

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research Excerpts

ExcerptRelevanceReference
"Nalidixic acid is a synthetic antibiotic discovered in the 1960s during the synthesis of chloroquine, an effective drug for treating malaria."1.91Fluoroquinolone-induced Glycaemic Aberrations: Could Quinolones be Repurposed to Serve as New Antidiabetic Agents? ( Ayodele, O; Khanye, S; Mothibe, M; Sibiya, N, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ayodele, O1
Khanye, S1
Mothibe, M1
Sibiya, N1

Other Studies

1 other study available for nalidixic acid and Hypoglycemia

ArticleYear
Fluoroquinolone-induced Glycaemic Aberrations: Could Quinolones be Repurposed to Serve as New Antidiabetic Agents?
    Current reviews in clinical and experimental pharmacology, 2023, Volume: 18, Issue:1

    Topics: Blood Glucose; Fluoroquinolones; Humans; Hypoglycemia; Hypoglycemic Agents; Nalidixic Acid; Quinolon

2023